Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK; Department of Diabetes and Endocrinology, Queen Elizabeth University Hospital, Glasgow, UK.
Department of Diabetes & Endocrinology, St Thomas' Hospital, London, UK; Department of Diabetes & Endocrinology, King' s College London, UK.
Diabetes Res Clin Pract. 2021 May;175:108835. doi: 10.1016/j.diabres.2021.108835. Epub 2021 Apr 24.
The IDF-DAR guidance was most recently updated this year. The most notable change is the moving to a scoring system from a tabulated risk categorization to determine and classify the risk of harm from fasting derived from an online survey. This change may be appealing and is welcomed. However, such a system and the methodology underpinning it is not without limitations. This commentary highlights some of these limitations and the associated limited safe options available to individuals with diabetes desiring to fast during Ramadan. Overlooked clinical considerations that deserve formal recognition include the role of technology (aspects relating to glucose monitoring and/or insulin delivery) and previous experience of safe Ramadan fasting. Further, duration of fast (which can almost double in temperate regions from winter to summer) needs greater emphasis. We also advocate separate scoring systems for people with type 1 diabetes and complex type 2 diabetes. The guidance acknowledges fasting is an individual's decision, however the general message needs to be more person-centred and currently only presents a binary approach to fasting - all or nothing choices. We propose and discuss addition options including, trial fasting of voluntary fasts, starting the fast and terminating due to health and/or safety, intermittent fasting and winter fasting.
IDF-DAR 指南最近在今年进行了更新。最显著的变化是从表格风险分类改为评分系统,以通过在线调查来确定和分类因禁食而导致伤害的风险。这种变化可能具有吸引力,也受到欢迎。然而,这种系统及其背后的方法并非没有局限性。本评论强调了其中的一些局限性,以及糖尿病患者在斋月期间禁食时可选择的有限安全方案。一些值得正式认可的被忽视的临床考虑因素包括技术的作用(与血糖监测和/或胰岛素输送相关的方面)和以前安全斋戒的经验。此外,禁食的持续时间(在温带地区,从冬季到夏季几乎翻了一番)需要更加重视。我们还主张为 1 型糖尿病和复杂 2 型糖尿病患者制定单独的评分系统。该指南承认禁食是个人的决定,但总体信息需要更加以患者为中心,目前仅提供一种禁食的二元方法——全或无的选择。我们提出并讨论了一些附加选择,包括自愿禁食的试验性禁食、开始禁食和因健康和/或安全原因终止禁食、间歇性禁食和冬季禁食。